These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30528792)

  • 1. An overview of statistical methods for handling nonadherence to intervention protocol in randomized control trials: a methodological review.
    Mostazir M; Taylor RS; Henley W; Watkins E
    J Clin Epidemiol; 2019 Apr; 108():121-131. PubMed ID: 30528792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonadherence to treatment protocol in published randomised controlled trials: a review.
    Dodd S; White IR; Williamson P
    Trials; 2012 Jun; 13():84. PubMed ID: 22709676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
    Merrill PD; McClure LA
    Trials; 2015 Nov; 16():523. PubMed ID: 26573840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Reporting of Treatment Nonadherence and Its Associated Impact on Economic Evaluations Conducted Alongside Randomized Trials: A Systematic Review.
    Brilleman SL; Metcalfe C; Peters TJ; Hollingworth W
    Value Health; 2016 Jan; 19(1):99-108. PubMed ID: 26797242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data.
    Chen H; Geng Z; Zhou XH
    Biometrics; 2009 Sep; 65(3):675-82. PubMed ID: 18759847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninferiority trials with nonadherence to the assigned randomized treatment.
    Korn EL; Gray RJ; Freidlin B
    Clin Trials; 2019 Dec; 16(6):673-681. PubMed ID: 31409130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.
    Antonelli J; Han B; Cefalu M
    Stat Med; 2017 Dec; 36(29):4604-4615. PubMed ID: 28833307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting approaches for addressing non-adherence in randomized controlled trials: An illustration from the REFLUX trial.
    Keele L; Grieve R
    Clin Trials; 2022 Feb; 19(1):97-106. PubMed ID: 34949104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Per-Protocol analyses produced larger treatment effect sizes than intention to treat: a meta-epidemiological study.
    Mostazir M; Taylor G; Henley WE; Watkins ER; Taylor RS
    J Clin Epidemiol; 2021 Oct; 138():12-21. PubMed ID: 34161805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical methods for handling compliance in randomized controlled trials of device interventions: a systematic review.
    Fiorentino F; Nóhpal de la Rosa C; Day E
    J Clin Epidemiol; 2022 Dec; 152():226-237. PubMed ID: 36183902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological Papers.
    Alshreef A; Latimer N; Tappenden P; Wong R; Hughes D; Fotheringham J; Dixon S
    Med Decis Making; 2019 Nov; 39(8):910-925. PubMed ID: 31646932
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contamination in trials of educational interventions.
    Keogh-Brown MR; Bachmann MO; Shepstone L; Hewitt C; Howe A; Ramsay CR; Song F; Miles JN; Torgerson DJ; Miles S; Elbourne D; Harvey I; Campbell MJ
    Health Technol Assess; 2007 Oct; 11(43):iii, ix-107. PubMed ID: 17935683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A framework for the design, conduct and interpretation of randomised controlled trials in the presence of treatment changes.
    Dodd S; White IR; Williamson P
    Trials; 2017 Oct; 18(1):498. PubMed ID: 29070048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of statistical methods for analysing survival data in the presence of non-random compliance.
    Odondi L; McNamee R
    Stat Med; 2010 Dec; 29(29):2994-3003. PubMed ID: 20963732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of methods for estimating the causal effect of a treatment in randomized clinical trials subject to noncompliance.
    Little RJ; Long Q; Lin X
    Biometrics; 2009 Jun; 65(2):640-9. PubMed ID: 18510650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intention to treat, per protocol, as treated and instrumental variable estimators given non-compliance and effect heterogeneity.
    McNamee R
    Stat Med; 2009 Sep; 28(21):2639-52. PubMed ID: 19579227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.